Europe is risking ‘health sovereignty’ by underpaying for drugs, says AstraZeneca

Financial Times November 06, 2025

Upvote 0 Downvote

CEO warns continent’s advantage in the industry could fade as companies build new high-tech factories elsewhere

Read Full Article

0 Comments

Comments 0

Log in to post a comment.

No comments yet. Be the first to comment!

Related News

Brussels opens probe into Deutsche Börse and Nasdaq over de…
Nov 06, 2025 Financial Times
Trump steps up military threats against Nigeria over attack…
Nov 06, 2025 Financial Times
UK construction activity falls at fastest pace for 5 years
Nov 06, 2025 Financial Times
Bank of England set for close vote on interest rates
Nov 06, 2025 Financial Times
The quest for an anti-Trumpian economic consensus
Nov 06, 2025 Financial Times

Source Information

Financial Times

Published on November 06, 2025